918 Deming Way Suite 201,
Madison, Wisconsin 53717-1944
EraGen Biosciences develops and commercializes high performance molecular diagnostics and drug discovery products to capitalize on the rapidly growing market for personalized medicine and rapid response needs for bioterrorism. EraGen's approach to gene-based research helps customers, partners and collaborators drive their genetic diagnostics and drug development efforts to the patient faster.
EraGen Biosciences was acquired by Luminex on June 21, 2011.
Join Mergr to view all 163 acquisitions of life science companies in 2011, including 18 acquisitions by private equity firms, and 145 by strategics.
Join Mergr to view this profile - and discover more life science acquisitions of companies like EraGen Biosciences.
No obligation. Cancel anytime.